Enovis Opens New Global Business Technology Centre in Lisbon to Support Growth


LISBON, PORTUGAL MAY 15, 2024—Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced the opening of its new business technology centre in Lisbon, Portugal. The Enovis Global Business Technology Centre will serve as a hub for the Company’s international Prevention & Recovery (P&R) group and focus on enabling automation, developing best-in-class digital capabilities, and integrating artificial intelligence to optimize workflows and drive a world-class customer experience.

The Enovis Global Business Technology Centre has the capacity of hosting 100 employees, and Enovis plans to recruit 40 of those team members by the end of 2024 to serve end-to-end finance and business operations while also acting as a digital platform for supply chain, sales, and customer experience applications. Other career opportunities are under evaluation. At launch, the Centre will serve most countries in Europe, and in the future, Canada and beyond. Led by Elisabeth Drouffe, an experienced global shared services leader, the Centre will also act as an interactive meeting space for Kaizens, trainings, and international Enovis events.

“With our rapid growth, diverse businesses and strong innovation pipeline, we knew it was time to establish a business technology centre in a central location that could scale with us,” said Cathal O’Donnell, President of International P&R at Enovis. “Lisbon was the perfect choice with its vibrant tech scene, multicultural, skilled talent and great quality of life.”

With 20 acquisitions since 2019, market leading positions in bracing, sports medicine, digital health, and advanced rehabilitation modules, and a fast-growing reconstructive surgery business, Enovis has been rapidly expanding around the world. The Company’s investment in regional centers of excellence like the Enovis Global Business Centre will create strategic advantage, enable further globalization in key innovation areas, and ultimately help Enovis continue to develop game-changing medical technology that improves patient outcomes.

“We are excited to welcome MedTech leader Enovis to Lisbon,” said Filipe Santos Costa, Chairman & CEO of AICEP, Portugal’s Trade & Investment Agency. “Portugal offers a robust digital infrastructure to thrive and innovate on a global scale and this new foreign investment is yet another good example of the country's position as a tech hub in Europe.”

About Enovis

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.

Media Contact
Katie Sweet
Vice President, Corporate Communications
Enovis Corporation